{"transactions":[{"id":1320958,"issuer":{"id":7876,"kind":"organization","name":"Quoin Pharmaceuticals Ltd."},"owners":[{"id":84718,"kind":"person","name":"Dunn Gordon","position":1,"cik":"0001958139","reported_name":"Dunn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series G Warrants (right to buy)","published_at":"2024-12-27T22:16:15.000Z","date":"2024-12-23","kind":"purchase","planned":false,"acquired":true,"shares":122221,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Each ADS purchased together with a Series F Warrant to purchase one ADS and a Series G Warrant to purchase one ADS in the Issuer's public offering which closed on December 23, 2024, at a combined public offering price of $0.45. The Series F Warrants and the Series G Warrants are collectively referred to as the \"Warrants.\""},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each ADS purchased together with a Series F Warrant to purchase one ADS and a Series G Warrant to purchase one ADS in the Issuer's public offering which closed on December 23, 2024, at a combined public offering price of $0.45. The Series F Warrants and the Series G Warrants are collectively referred to as the \"Warrants.\""},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Warrants were exercisable immediately, subject to a beneficial ownership cap."}],"balance_after":122221,"derivative":{"exercise_price":0.45,"exercise_date":"2024-12-23","expiration_date":"2029-12-24","underlying":"ADS","underlying_shares":122221},"source":{"system":"sec-edgar","filing":"0001104659-24-132187","document":"tm2431988-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465924132187/tm2431988-2_4seq1.xml","form_type":"4"}},{"id":1320957,"issuer":{"id":7876,"kind":"organization","name":"Quoin Pharmaceuticals Ltd."},"owners":[{"id":84718,"kind":"person","name":"Dunn Gordon","position":1,"cik":"0001958139","reported_name":"Dunn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series F Warrants (right to buy)","published_at":"2024-12-27T22:16:15.000Z","date":"2024-12-23","kind":"purchase","planned":false,"acquired":true,"shares":122221,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Each ADS purchased together with a Series F Warrant to purchase one ADS and a Series G Warrant to purchase one ADS in the Issuer's public offering which closed on December 23, 2024, at a combined public offering price of $0.45. The Series F Warrants and the Series G Warrants are collectively referred to as the \"Warrants.\""},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each ADS purchased together with a Series F Warrant to purchase one ADS and a Series G Warrant to purchase one ADS in the Issuer's public offering which closed on December 23, 2024, at a combined public offering price of $0.45. The Series F Warrants and the Series G Warrants are collectively referred to as the \"Warrants.\""},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Warrants were exercisable immediately, subject to a beneficial ownership cap."}],"balance_after":122221,"derivative":{"exercise_price":0.45,"exercise_date":"2024-12-23","expiration_date":"2026-12-23","underlying":"ADS","underlying_shares":122221},"source":{"system":"sec-edgar","filing":"0001104659-24-132187","document":"tm2431988-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465924132187/tm2431988-2_4seq1.xml","form_type":"4"}},{"id":1320956,"issuer":{"id":7876,"kind":"organization","name":"Quoin Pharmaceuticals Ltd."},"owners":[{"id":84718,"kind":"person","name":"Dunn Gordon","position":1,"cik":"0001958139","reported_name":"Dunn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2024-12-27T22:16:15.000Z","date":"2024-12-23","kind":"purchase","planned":false,"acquired":true,"shares":122221,"price":0.45,"value":54999.45,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary share of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Each ADS purchased together with a Series F Warrant to purchase one ADS and a Series G Warrant to purchase one ADS in the Issuer's public offering which closed on December 23, 2024, at a combined public offering price of $0.45. The Series F Warrants and the Series G Warrants are collectively referred to as the \"Warrants.\""}],"balance_after":151077,"source":{"system":"sec-edgar","filing":"0001104659-24-132187","document":"tm2431988-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465924132187/tm2431988-2_4seq1.xml","form_type":"4"}},{"id":1337200,"issuer":{"id":7876,"kind":"organization","name":"Quoin Pharmaceuticals Ltd."},"owners":[{"id":84718,"kind":"person","name":"Dunn Gordon","position":1,"cik":"0001958139","reported_name":"Dunn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2024-12-10T21:51:56.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":338994,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary share of the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in four annual installments with 20% vesting on each of December 9, 2025, 2026 and 2027 and 40% vesting on December 9, 2028."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary share of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary share of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary share of the Issuer."}],"balance_after":338994,"derivative":{"exercise_price":0.78,"expiration_date":"2034-12-09","underlying":"ADS","underlying_shares":338994},"source":{"system":"sec-edgar","filing":"0001104659-24-127243","document":"tm2430519-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465924127243/tm2430519-7_4seq1.xml","form_type":"4"}},{"id":1409769,"issuer":{"id":7876,"kind":"organization","name":"Quoin Pharmaceuticals Ltd."},"owners":[{"id":84718,"kind":"person","name":"Dunn Gordon","position":1,"cik":"0001958139","reported_name":"Dunn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2024-09-11T20:30:08.000Z","date":"2024-09-10","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.71,"value":7100.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary shares of the Issuer."}],"balance_after":28856,"source":{"system":"sec-edgar","filing":"0001104659-24-098940","document":"tm2423807-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465924098940/tm2423807-1_4seq1.xml","form_type":"4"}},{"id":1409768,"issuer":{"id":7876,"kind":"organization","name":"Quoin Pharmaceuticals Ltd."},"owners":[{"id":84718,"kind":"person","name":"Dunn Gordon","position":1,"cik":"0001958139","reported_name":"Dunn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2024-09-11T20:30:08.000Z","date":"2024-09-10","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.91,"value":9100.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary shares of the Issuer."}],"balance_after":18856,"source":{"system":"sec-edgar","filing":"0001104659-24-098940","document":"tm2423807-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465924098940/tm2423807-1_4seq1.xml","form_type":"4"}},{"id":1409767,"issuer":{"id":7876,"kind":"organization","name":"Quoin Pharmaceuticals Ltd."},"owners":[{"id":84718,"kind":"person","name":"Dunn Gordon","position":1,"cik":"0001958139","reported_name":"Dunn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2024-09-11T20:30:08.000Z","date":"2024-09-09","kind":"purchase","planned":false,"acquired":true,"shares":4000,"price":0.8,"value":3200.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary shares of the Issuer."}],"balance_after":8856,"source":{"system":"sec-edgar","filing":"0001104659-24-098940","document":"tm2423807-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465924098940/tm2423807-1_4seq1.xml","form_type":"4"}},{"id":1409766,"issuer":{"id":7876,"kind":"organization","name":"Quoin Pharmaceuticals Ltd."},"owners":[{"id":84718,"kind":"person","name":"Dunn Gordon","position":1,"cik":"0001958139","reported_name":"Dunn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2024-09-11T20:30:08.000Z","date":"2024-09-09","kind":"purchase","planned":false,"acquired":true,"shares":4000,"price":0.78,"value":3120.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary shares of the Issuer."}],"balance_after":4856,"source":{"system":"sec-edgar","filing":"0001104659-24-098940","document":"tm2423807-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465924098940/tm2423807-1_4seq1.xml","form_type":"4"}},{"id":1409765,"issuer":{"id":7876,"kind":"organization","name":"Quoin Pharmaceuticals Ltd."},"owners":[{"id":84718,"kind":"person","name":"Dunn Gordon","position":1,"cik":"0001958139","reported_name":"Dunn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2024-09-11T20:30:08.000Z","date":"2024-09-09","kind":"purchase","planned":false,"acquired":true,"shares":856,"price":0.8,"value":684.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary shares of the Issuer."}],"balance_after":856,"source":{"system":"sec-edgar","filing":"0001104659-24-098940","document":"tm2423807-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465924098940/tm2423807-1_4seq1.xml","form_type":"4"}},{"id":1753829,"issuer":{"id":7876,"kind":"organization","name":"Quoin Pharmaceuticals Ltd."},"owners":[{"id":84718,"kind":"person","name":"Dunn Gordon","position":1,"cik":"0001958139","reported_name":"Dunn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2023-10-30T20:12:21.000Z","date":"2023-10-26","kind":"grant","planned":false,"acquired":true,"shares":51149,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"), with sixty thousand (60,000) ordinary shares of the Issuer represented by one (1) ADS."},{"field":"shares","element":"transactionShares","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"), with sixty thousand (60,000) ordinary shares of the Issuer represented by one (1) ADS."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in four annual installments with 20% vesting on each of October 26, 2024, 2025 and 2026 and 40% vesting on October 26, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"), with sixty thousand (60,000) ordinary shares of the Issuer represented by one (1) ADS."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"), with sixty thousand (60,000) ordinary shares of the Issuer represented by one (1) ADS."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"), with sixty thousand (60,000) ordinary shares of the Issuer represented by one (1) ADS."}],"balance_after":51149,"derivative":{"exercise_price":5.75,"exercise_date":"2024-10-26","expiration_date":"2033-10-26","underlying":"American Depositary Share","underlying_shares":51149},"source":{"system":"sec-edgar","filing":"0001104659-23-112570","document":"tm2329341-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465923112570/tm2329341-4_4seq1.xml","form_type":"4"}}]}